Pharma Mar Balance Sheet Health
Financial Health criteria checks 4/6
Pharma Mar has a total shareholder equity of €182.2M and total debt of €50.8M, which brings its debt-to-equity ratio to 27.9%. Its total assets and total liabilities are €333.1M and €151.0M respectively.
Key information
27.9%
Debt to equity ratio
€50.84m
Debt
| Interest coverage ratio | n/a |
| Cash | €144.39m |
| Equity | €182.17m |
| Total liabilities | €150.96m |
| Total assets | €333.13m |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: PHMM.F's short term assets (€238.0M) exceed its short term liabilities (€89.4M).
Long Term Liabilities: PHMM.F's short term assets (€238.0M) exceed its long term liabilities (€61.5M).
Debt to Equity History and Analysis
Debt Level: PHMM.F has more cash than its total debt.
Reducing Debt: PHMM.F had negative shareholder equity 5 years ago, but is now positive and has therefore improved.
Debt Coverage: PHMM.F's debt is not well covered by operating cash flow (3.2%).
Interest Coverage: Insufficient data to determine if PHMM.F's interest payments on its debt are well covered by EBIT.